Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL

Clinical trial NCT01728805 · COMPLETED

Trial details

NCT number: NCT01728805
Sponsor: Kyowa Kirin, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cutaneous T-Cell Lymphoma

Start date: 2012-11-01
Primary completion: 2017-03-01
Enrollment: 372

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.